Alexion Pharmaceuticals
Irfan Ali Mohammed, MS, is an experienced professional in pharmaceutical development, currently serving as Director CMC Team Lead for Product Development and Clinical Supply at Alexion Pharmaceuticals, Inc. Since December 2020, Irfan has been responsible for leading the Global CMC Development Strategy for the Factor D Portfolio, overseeing a $90 million budget and guiding interdisciplinary teams from pre-clinical through commercialization. Previously, Irfan held roles at Nevakar Inc., focusing on formulation R&D and leading significant cost-saving projects, and at Teligent, Inc., as their first R&D scientist for sterile product development. Irfan's educational background includes a Ph.D. in Pharmaceutics and a Master of Science in Industrial Pharmacy.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.